Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | HPGD | P15428 | 3/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | CHRM3 | P20309 | 3/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11930692 | 0.89 | ALDH1A1 (0.57) | ALDH1A1HPGDSMN1; SMN2LMNACYP1A2 | |
| SCHEMBL1134832 | 0.88 | ALDH1A1 (0.47) | ALDH1A1HPGDSMN1; SMN2LMNACYP1A2 | |
| SCHEMBL4920981 | 0.86 | CHRM3 (0.48) | ALDH1A1HPGDSMN1; SMN2LMNACYP1A2 | |
| SCHEMBL4918689 | 0.86 | CHRM3 (0.50) | ALDH1A1HPGDSMN1; SMN2LMNACYP1A2 | |
| SCHEMBL4449299 | 0.84 | CHRM3 (0.48) | ALDH1A1HPGDSMN1; SMN2LMNACYP1A2 | |
| SCHEMBL4456891 | 0.84 | CHRM3 (0.50) | ALDH1A1HPGDSMN1; SMN2CYP1A2CYP2C9 | |
| SCHEMBL3547306 | 0.82 | MEN1 (0.54) | ALDH1A1HPGDSMN1; SMN2LMNACYP1A2 | |
| SCHEMBL1134848 | 0.82 | ALDH1A1 (0.47) | ALDH1A1HPGDSMN1; SMN2LMNACYP1A2 | |
| SCHEMBL29445379 | 0.82 | ALDH1A1 (0.47) | ALDH1A1HPGDSMN1; SMN2LMNACYP1A2 | |
| SCHEMBL11035162 | 0.81 | HPGD (0.70) | ALDH1A1HPGDSMN1; SMN2LMNACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080153707-A1 | Pyrazolecarboxanilides, Process for Their Preparation and Compositions Comprising Them for Controlling Harmful Fungi | BASF AKITENGESELLSCHAFT (DE) | 2008-06-26 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080153707-A1 | Pyrazolecarboxanilides, Process for Their Preparation and Compositions Comprising Them for Controlling Harmful Fungi | CBR3, C1S, PYM1 | ALDH1A1 4489/4885HPGD 3433/4885SMN1; SMN2 4329/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.